Terug
Dagbereik
€ 53,91
€ 56,29
52-Weeksbereik
€ 26,74
€ 63,95
Volume
1.716.561
50D / 200D Gem.
€ 45,08
/
€ 39,69
Vorige Slotkoers
€ 53,38
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -13,4 | 0,2 |
| P/B | 8,0 | 3,0 |
| ROE % | -51,8 | 3,6 |
| Net Margin % | -4612,1 | 3,8 |
| Rev Growth 5Y % | -20,1 | 9,9 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 76,67
+38.0%
Low: € 44,00
High: € 100,00
Forward WPA
-€ 4,80
Omzet Sch.
4,42M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 5,26
-€ 0,12 – € 14,65
|
1,25B | 5 |
| FY2029 |
€ 1,59
-€ 0,04 – € 4,43
|
790,90M | 11 |
| FY2028 |
-€ 2,95
-€ 5,82 – € 1,54
|
282,17M | 13 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -€ 1,19 | -€ 1,31 | -9,9% |
| 2025-11-03 | -€ 1,16 | -€ 1,15 | +0,9% |
| 2025-08-11 | -€ 1,03 | -€ 1,07 | -3,9% |
| 2025-05-12 | -€ 0,94 | -€ 0,83 | +11,7% |
| 2025-02-27 | -€ 0,89 | -€ 0,84 | +5,6% |
| 2024-11-12 | -€ 0,82 | -€ 0,81 | +0,7% |
| 2024-08-08 | -€ 0,72 | -€ 0,75 | -4,2% |
| 2024-05-09 | -€ 0,69 | -€ 0,62 | +10,1% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue declined -20,14% annually over 5 years
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -279,92M
Groei
Revenue Growth (5Y)
-20,14%
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-51,76%
ROIC-47,45%
Net Margin-4612,13%
Op. Margin-4974,27%
Veiligheid
Debt / Equity
0,01
Current Ratio13,42
Interest Coverage0,00
Waardering
P/E Ratio
-13,36
Forward P/EN/A
P/B Ratio7,95
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -20,14% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7,50M | Net Income (TTM) | -345,91M |
| ROE | -51,76% | ROA | -35,24% |
| Gross Margin | 66,09% | Operating Margin | -4974,27% |
| Net Margin | -4612,13% | Free Cash Flow (TTM) | -279,92M |
| ROIC | -47,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 13,42 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -13,36 | Forward P/E | N/A |
| P/B Ratio | 7,95 | P/S Ratio | 616,38 |
| PEG Ratio | -0,23 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1046,26 | Fwd Earnings Yield | N/A |
| FCF Yield | -6,06% | ||
| Market Cap | 4,62B | Enterprise Value | 4,43B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,50M | 0,0 | 0,0 | 9,43M | 18,44M |
| Net Income | -345,91M | -234,33M | -182,39M | -125,37M | -78,88M |
| EPS (Diluted) | -4,36 | -3,01 | -2,73 | -2,06 | -1,77 |
| Gross Profit | 4,96M | -2,56M | -167,51M | 9,43M | 18,44M |
| Operating Income | -373,07M | -279,30M | -214,05M | -129,14M | -78,99M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 981,67M | 798,14M | 964,80M | 754,15M | 572,01M |
| Total Liabilities | 399,91M | 43,24M | 36,88M | 32,65M | 21,97M |
| Shareholders' Equity | 581,76M | 754,90M | 927,92M | 721,50M | 550,03M |
| Total Debt | 7,94M | 9,02M | 10,90M | 10,44M | 8,26M |
| Cash & Equivalents | 199,16M | 142,71M | 148,64M | 57,24M | 175,69M |
| Current Assets | 560,65M | 635,26M | 644,96M | 600,30M | 559,02M |
| Current Liabilities | 41,79M | 35,59M | 27,27M | 22,70M | 14,32M |